Advances in HIV-1 Vaccine Development

Advances in HIV-1 Vaccine Development

An efficacious HIV-1 vaccine is regarded as the best way to halt the ongoing HIV-1 epidemic. However, despite significant efforts to develop a safe and effective vaccine, the modestly protective RV144 trial remains the only efficacy trial to provide some level of protection against HIV-1 acquisition...

Full description

Bibliographic Details
Main Authors:	Yong Gao, Paul F. McKay, Jamie F. S. Mann
Format:	Article
Language:	English
Published:	MDPI AG 2018-04-01
Series:	Viruses
Subjects:	HIV-1 vaccine antibodies immunogen neutralization
Online Access:	http://www.mdpi.com/1999-4915/10/4/167

Similar Items

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
by: Yong Gao, et al.
Published: (2018-02-01)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
by: Amyn A. Murji, et al.
Published: (2021-07-01)

Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development
by: Delphine C. Malherbe, et al.
Published: (2020-06-01)

Peptide-Based Vaccination for Antibody Responses Against HIV
by: Behazine Combadière, et al.
Published: (2019-09-01)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence
by: Yuka Nadai, et al.
Published: (2019-04-01)

The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination
by: Yonas Bekele Feyissa, et al.
Published: (2021-02-01)

Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
by: Beatriz Perdiguero, et al.
Published: (2018-08-01)

Editorial for Research Topic : Paradigm changes are required in HIV vaccine research
by: Marc H V Van Regenmortel
Published: (2015-06-01)

Neutralization-enhancing RF antibodies for HIV vaccines
by: Konstantin V Suslov
Published: (2014-12-01)

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
by: Huan Liu, et al.
Published: (2018-04-01)

HIV-1/SIV Neutralizing Antibody Gene Delivery: A Novel Vaccination Approach
by: Zhang, Jian Chao
Published: (2009)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
by: Zanele Ditse, et al.
Published: (2020-01-01)

Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques
by: Roger Le Grand, et al.
Published: (2013-07-01)

A new scientific paradigm may be needed to finally develop an HIV vaccine.
by: Jose eEsparza
Published: (2015-03-01)

Redefining Non-Inferiority in Anamnestic Antibody Responses Using the Mean Increase of Log-Transformed Antibody Titers after Revaccination: Secondary Analysis of a Randomized Controlled Rabies Vaccination Trial
by: Lisanne A. Overduin, et al.
Published: (2020-12-01)

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
by: Andrey P. Rudometov, et al.
Published: (2019-08-01)

Env-Specific Antibodies in Chronic Infection versus in Vaccination
by: Martina Soldemo, et al.
Published: (2017-09-01)

Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors
by: Xiaoli Zhang, et al.
Published: (2012-12-01)

Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors
by: Xiaoli Zhang, et al.

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
by: Chun-Wei Chen, et al.
Published: (2020-09-01)

POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS
by: R. G. Yapparov, et al.
Published: (2018-04-01)

Impact of HIV-1 Diversity on Its Sensitivity to Neutralization
by: Karl Stefic, et al.
Published: (2019-07-01)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
by: Garnett Kelsoe, et al.
Published: (2013-12-01)

High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm
by: Andreas Roetzer, et al.
Published: (2020-10-01)

The Role of Maternal HIV Envelope-Specific Antibodies and Mother-to-Child Transmission Risk
by: Ayooluwa O. Douglas, et al.
Published: (2017-09-01)

Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
by: Alexander W Kay, et al.
Published: (2015-06-01)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
by: Sarah Wilmschen, et al.
Published: (2019-09-01)

Elicitation of broadly neutralizing antibodies against HIV-1 – the germline/maturation hypothesis
by: Prabakaran ePonraj, et al.
Published: (2014-08-01)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
by: Chakraborty, A.K, et al.
Published: (2022)

Broad Neutralization as a Byproduct of Antibody Maturation during HIV-1 Infection: a Personal Perspective
by: Feng Gao
Published: (2016-07-01)

Origin, diversity and maturation of human antiviral antibodies analyzed by high-throughput sequencing
by: Ponraj ePrabakaran, et al.
Published: (2012-08-01)

Targeting The CD4 Biniding Site In HIV-1 Immunogen Design
by: Bhattacharyya, Sanchari
Published: (2016)

Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
by: Kevin O. Saunders, et al.
Published: (2017-12-01)

Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
by: Marcel Tongo, et al.
Published: (2014-10-01)

Which antibody functions are important for an HIV vaccine ?
by: Bin eSu, et al.
Published: (2014-06-01)

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies
by: Christiane Moog, et al.
Published: (2009-12-01)

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation
by: Rosamund Chapman, et al.
Published: (2019-06-01)

Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies
by: Christoph Kreer, et al.
Published: (2020-01-01)

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
by: Jasmine Davda, et al.
Published: (2019-04-01)